ALERT: This system is being upgraded on Tuesday December 12. It will not be available
for use for several hours that day while the upgrade is in progress. Deposits to DukeSpace
will be disabled on Monday December 11, so no new items are to be added to the repository
while the upgrade is in progress. Everything should be back to normal by the end of
day, December 12.
Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals.
Abstract
BACKGROUND: The isolation of human monoclonal antibodies (mAbs) that neutralize a
broad spectrum of primary HIV-1 isolates and the characterization of the human neutralizing
antibody B cell response to HIV-1 infection are important goals that are central to
the design of an effective antibody-based vaccine. METHODS AND FINDINGS: We immortalized
IgG(+) memory B cells from individuals infected with diverse clades of HIV-1 and selected
on the basis of plasma neutralization profiles that were cross-clade and relatively
potent. Culture supernatants were screened using various recombinant forms of the
envelope glycoproteins (Env) in multiple parallel assays. We isolated 58 mAbs that
were mapped to different Env surfaces, most of which showed neutralizing activity.
One mAb in particular (HJ16) specific for a novel epitope proximal to the CD4 binding
site on gp120 selectively neutralized a multi-clade panel of Tier-2 HIV-1 pseudoviruses,
and demonstrated reactivity that was comparable in breadth, but distinct in neutralization
specificity, to that of the other CD4 binding site-specific neutralizing mAb b12.
A second mAb (HGN194) bound a conserved epitope in the V3 crown and neutralized all
Tier-1 and a proportion of Tier-2 pseudoviruses tested, irrespective of clade. A third
mAb (HK20) with broad neutralizing activity, particularly as a Fab fragment, recognized
a highly conserved epitope in the HR-1 region of gp41, but showed striking assay-dependent
selectivity in its activity. CONCLUSIONS: This study reveals that by using appropriate
screening methods, a large proportion of memory B cells can be isolated that produce
mAbs with HIV-1 neutralizing activity. Three of these mAbs show unusual breadth of
neutralization and therefore add to the current panel of HIV-1 neutralizing antibodies
with potential for passive protection and template-based vaccine design.
Type
Journal articleSubject
Amino Acid SequenceAntibodies, Monoclonal
Antibodies, Neutralizing
Antigens, CD4
B-Lymphocytes
Binding Sites, Antibody
Epitopes
HIV Infections
HIV-1
Humans
Immunologic Memory
Molecular Sequence Data
Permalink
https://hdl.handle.net/10161/4523Published Version (Please cite this version)
10.1371/journal.pone.0008805Publication Info
Corti, Davide; Langedijk, Johannes PM; Hinz, Andreas; Seaman, Michael S; Vanzetta,
Fabrizia; Fernandez-Rodriguez, Blanca M; ... Lanzavecchia, Antonio (2010). Analysis of memory B cell responses and isolation of novel monoclonal antibodies with
neutralizing breadth from HIV-1-infected individuals. PLoS One, 5(1). pp. e8805. 10.1371/journal.pone.0008805. Retrieved from https://hdl.handle.net/10161/4523.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
David Charles Montefiori
Professor in Surgery
Dr. Montefiori is Professor and Director of the Laboratory for HIV and COVID-19 Vaccine
Research & Development in the Department of Surgery, Division of Surgical Sciences
at Duke University Medical Center. His major research interests are viral immunology
and HIV and COVID-19 vaccine development, with a special emphasis on neutralizing
antibodies. Multiple aspects of HIV-1 neutralizing antibodies are studied in his laboratory,
including mechanisms of neutralization and escape,

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info